To the Editor In the context of the expanding adoption of de-escalation strategies for medullary thyroid carcinoma (MTC), we read with great interest the systematic review and meta-analysis by Lincango et al. This study supports thyroid lobectomy (TL) as treatment option for sporadic MTC, with outcomes comparable with total thyroidectomy (TT) as recommended by guidelines. However, several methodological and clinical issues deserve further consideration.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Further Methodological and Clinical Reflections—Reply | 0 | 0 | 11-06-2026 |
| 2 | Second Primary Malignant Neoplasms After T-Cell–Engaging Bispecific Antibody Therapy | 0 | 0 | 18-06-2026 |
| 3 | Artificial Intelligence–Based Risk Prediction Models for Complications After Tongue Cancer Surgery | 0 | 0 | 18-06-2026 |
| 4 | Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer | 0 | 0 | 18-06-2026 |
| 5 | Дифференциальная диагностика лимфаденопатий: просто о сложном | 0 | 0 | 22-06-2026 |
| 6 | A Pulsatile Peritonsillar Mass | 0 | 0 | 11-06-2026 |
| 7 | Апоплексия яичника: оценка региональных особенностей, факторов риска и современных подходов к органосохраняющему лечению | 0 | 0 | 16-06-2026 |
| 8 | Беременность, осложненная раком шейки матки: современные подходы к лечению в отечественной литературе | 0 | 0 | 16-06-2026 |
| 9 | Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer | 0 | 0 | 18-06-2026 |
| 10 | Survival in the SONIA Trial | 0 | 0 | 18-06-2026 |